Alcohol Intake and Bone Microarchitecture Deterioration in Older Men: The Prospective Structure of Aging Men’s Bones (STRAMBO) Study Authors: Pawel Szulc, Danielle E. Whittier, Steven K. Boyd, Roland Chapurlat Published: 2026 ABSTRACT BackgroundData on the link between alcohol intake and prospectively assessed changes in areal bone mineral density (aBMD) are scarce. Our aim was to assess the association of alcohol intake with bone loss and microarchitectural decline prospectively assessed in older men.MethodsIn 818 men aged 60 to 87 years, bone microarchitecture was assessed at the distal radius and distal tibia (XtremeCT; Scanco Medical). Areal aBMD was assessed by dual energy X-ray absorptiometry (Hologic Inc.). Both were assessed at baseline, then after 4 and 8 years. Linear mixed models were adjusted for age, body mass index, bioavailable 17β-estradiol, osteoprotegerin, parathyroid hormone, Creactive protein and for grip strength (radius) or for the lower limb physical function score (tibia).ResultsAt baseline, aBMD and bone microarchitecture measures did not differ across the classes of alcohol intake. During the follow-up, aBMD decrease did not vary differently across the classes of alcohol intake. Men drinking 16 to 112 g alcohol per week had the slowest bone microarchitecture decline (reference group). At the distal radius, trabecular BMD (Tb.BMD) and number (Tb.N) decreased faster in men consuming <16 g/week and in men drinking >224 g/week vs. the reference group. At the distal tibia, cortical thickness (Ct.Thd), cortical area (Ct.Ar), reaction force, and failure load decreased faster in men consuming <16 g/week and in men drinking >224 g/week versus the reference group.ConclusionsModerate alcohol intake is associated with slower bone decline. Very low and higher alcohol intake were associated with faster bone microarchitecture deterioration in older men when assessed prospectively. GRAPHICAL ABSTRACT INTRODUCTION Osteoporosis in older men is a major public health problem. The risk of fracture is lower in men than in women,[1] but the consequences of fracture in terms of morbidity, mortality and loss of independence are more serious in men.[2] Although lower areal bone mineral density (aBMD) is associated with a higher risk of fracture in both sexes, the percentage of fractures which occur in subjects with aBMD above the osteoporosis threshold (T-score=−2.5) is higher in men than women.[3] Thus, we need to look for other risk factors to identify men at high risk of fracture. In this context, alcohol intake is interesting because many studies assessed its association with aBMD and bone fragility. They show that alcohol intake is associated with lower bone formation.[4,5] Some studies also show that alcohol drinking is associated with higher bone resorption.[5,6] Regular or heavy drinking is associated with higher fracture risk after adjusting for confounders including aBMD.[7,8] However, in heavy drinkers high fracture risk may be also due to high risk of trauma, poor muscle strength and impaired balance.[9,10] Data on the link between alcohol intake and bone status are discordant. Higher alcohol intake was associated with lower,[4,11] higher [9,12–14] or similar aBMD [15] vs. those who drink less. In some studies, the patterns differed according to the sex and skeletal site.[16–18] The association between alcohol intake and bone status may vary between cortical and trabecular compartments; however, data are scarce.[19] This topic is important because different effects of alcohol on cortical and trabecular bone may explain the discordant results in the available studies. Other factors may also contribute to the differences between studies. In cross-sectional studies, analyses of BMD according to the classes of current alcohol intake do not account for the former drinking habits. However, longer alcohol use is associated with lower aBMD.[15,20] The most popular type of alcohol varies across the countries. Wine and beer are less harmful for bone (even protective) than strong alcoholic beverages. Therefore, drinking small amounts may be associated with higher aBMD.[16] Current alcohol abstention may not be voluntary but related to poor bone health status, which may itself have an impact on bone metabolism and risk of fall.[21] Thus, current alcohol intake may not reflect life-long alcohol intake habits. Consequently, it may be associated not with the current bone status, but rather with its future changes. Therefore, our aim was to assess the association between the current alcohol intake and the prospectively assessed deterioration of bone microarchitecture in a prospectively followed cohort of older men. METHODS Cohort The Structure of Aging Men’s Bones (STRAMBO) study is a prospective cohort study of bone fragility in men [22] performed by institut national de la santé et de la recherche médicale (INSERM) and Mutuelle des Travailleurs de la Région Lyonnaise (MTRL), health insurance company. In 2006–2008, letters inviting participation were sent to randomly selected men insured by MTRL living in Greater Lyon. Men able to give informed consent, to answer questionnaires, and to participate in diagnostic tests were included. No specific exclusion criteria were used. Men aged ≥60 years (N=818) were prospectively followed for 8 years. The study obtained authorization from the local ethics committee and was performed in agreement with the Helsinki Declaration of 2004. Epidemiological questionnaire At baseline, men replied to interviewer-assisted questionnaires. To assess the alcohol intake, men reported what type of alcohol they drank (wine, beer, vodka, liquors, aperitif) and how many units of each alcohol per week on average. Weekly alcohol intake was estimated using average volumes of units of various types of alcohol as used in France and their average alcohol fraction. Based on this calculation, 1 unit was 16 g alcohol. Smoking and self-perceived health were self-reported. Physical activity was estimated by the time (hours/week) spent on leisure sport activity, walking and gardening. Calcium intake was estimated by a food-frequency questionnaire. Co-morbidities (ischemic heart disease, Parkinson disease, stroke, chronic obstructive pulmonary disease, prior cancer, diabetes mellitus, digestive tract diseases) and treatments were self-reported (Y/N). Hypertension was defined as a physician diagnosis or blood pressure above 140/90 mmHg. Grip strength was measured by a hand dynamometer (Martin Vigorimeter; Martin Gebrüder GmBH, Tuttlingen, Germany) at the dominant hand. [22] The physical performance score was estimated using clinical tests (chair stands, standing 10s with feet in the side-by-side position with eyes open or closed, 10-step tandem forward and backward walk).[23] It accounts for the ability and the time needed to perform each test. Microarchitecture assessment Volumetric BMD and microarchitecture were assessed at the nondominant distal radius and right distal tibia by high-resolution peripheral quantitative computed tomography (HR-pQCT; XtremeCT; Scanco Medical, Brüttisellen, Switzerland) at baseline and after 4 and 8 years. The volume of interest (VOI) was defined on a scout view.[22] A stack of 110 slices (voxel size 82 μm) corresponded to a three-dimensional segment of ~9 mm thickness. The distal limit was fixed at 9.5 and 22.5 mm proximal to the endplate of radius and tibia. Cortical thickness (Ct.Thd) was defined as cortical volume divided by outer bone surface (the superscript d denotes derived, calculated parameters to distinguish them from those which are directly measured). Trabecular BMD (Tb.BMD) was computed as average BMD in the trabecular VOI. Tb.BMD was also assessed in the outer subendocortical subcompartment (s.e.Tb.BMD) and the inner (central) one (inn.Tb.BMD). Trabecular number (Tb.N), trabecular thickness (Tb.Thd), trabecular separation (Tb. Spd) and trabecular distribution heterogeneity (Tb.1/N.SD) were derived using the software (Image Processing Language v5.16/FE v01.16).[24] A phantom (QRM GmbH, Möhrendorf, Germany) was scanned daily. CV for the densities was 0.1%–0.9%. In vivo CVs varied from 0.7% (Ct. BMD) to 4.4% (Tb.Thd). We excluded scans with motion artifacts (score ≥4) and those with <85% of overlap between the two consecutive scans.[22,25] At baseline, after 4 and 8 years of follow-up, 742 (91%), 573 (70%), and 400 (49%) men had good quality scans at distal radius. At these timepoints, 801 (98%), 622 (76%), and 434 (53%) men had good quality scans at distal tibia. Finite element (FE) analysis Micro FE (μFE) analysis was performed on the unregistered segmented HR-pQCT scans to determine reaction force and estimated failure load. Linear models were generated by the voxel-by-voxel approach, with Poisson’s ratio of 0.3 and homogeneous Young’s modulus of 6,829 GPa assigned as bone tissue properties.[26] The model boundary conditions were an axial compression with 1% compressive strain, and resultant reaction force of the bone was measured. Failure load was estimated using a yield criterion of 2% critical volume and 0.7% critical strain.[24] The μFE models were solved using a conjugate gradient approach with a convergence criterion of 1×10−6 (FAIM v8.0; Numerics88 Solutions Ltd., Calgary, Canada) on the University of Calgary’s High-performance computing cluster. Biological measurements At baseline, non-fasting serum was collected at 1:00 PM and stored at −80°C. Testosterone was measured by radioimmunoassay (RIA) after diethyl ether extraction.[27] 17β-estradiol (17β-E2) was measured by RIA (Cisbio Bioassays, Codolet, France).[28] Sex hormone-binding globulin was measured by RIA (Cisbio Bioassays).[28] Calculated free testosterone and bioavailable 17β-E2 (Bio-17β-E2) were derived as formerly described.[27] Parathyroid hormone (PTH) was assayed by immunochimiluminescence assay (Roche Diagnostics, Mannheim, Germany).[29] 25-hydroxy-vitamin D (25[OH]D) was assessed by RIA (DiaSorin, Stillwater, MN) after acetonitrile extraction.[29] High-sensitivity C-reactive protein (hs-CRP) was measured by immunoturbidimetric latex assay (Roche Diagnostics).[30] Osteoprotegerin (OPG) was measured by ELISA (Biomedica, Vienna, Austria). Creatinine was measured with a compensated kinetic Jaffe method (Roche Modular, Meylan, France) and glomerular filtration rate (GFR) was estimated with the Chronic Kidney Disease Epidemiology Collaboration equation. Dual energy X-ray absorptiometry (DXA) Areal BMD was measured at lumbar spine, total hip, whole body and non-dominant distal radius using a Hologic Discovery-A (Hologic Inc., Bedford, MA, USA). Its stability was assessed using the spine phantom measured daily (coefficient of variation [CV]=0.35%). The in vivo CV was 1.1% to 1.2%. Whole-body composition was assessed by DXA.[22] Relative appendicular lean mass is the sum of lean mass of both arms and legs divided by (height)2. Abdominal aortic calcification (AAC) severity score was assessed using Kauppila’s 24-point score on the lateral spine scans as described previously.[31] Statistical analyses We used the R 4.3.3 software (R Foundation for Statistical Computing, Vienna, Austria; https://www.r-project.org/). Continuous variables with Gaussian distribution are presented as mean and standard deviation (SD), those with skewed distribution as median and interquartile range (IQR), and categorical ones as percentage. The groups were categorized using the thresholds of alcohol intake: <16 g/week (<1 unit/week), 16 to 112 g/week (1–7 units/week), >112 to 224 g/week (>7 to 14 units/week) and >224 g/week (>14 units/week). Comparisons according to the alcohol intake categories were performed by analysis of covariance (ANCOVA). Categorical variables were analyzed using the χ2 test or Fisher’s exact test, with adjustment for age using the Cochran–Mantel–Haenszel test. Linear effect models were used to describe bone parameters at baseline. Linear mixed effect models were used to explore ageing-related changes in bone parameters according to the classes of alcohol intake. Models were adjusted for age, body mass index (BMI), hs-CRP, bio-17β-E2, PTH, diabetes mellitus, OPG, grip strength (for radius) and physical capacity score (for tibia). Bone indices were adjusted for significant variables and assessed with a linear mixed model and α =0.05. As this is an exploratory analysis of intercorrelated variables, we did not use correction for multiple comparisons. Subject identifier and age were used as random effects to account for the subject- and age-related variation in trajectories. Percentage changes were assessed using the log-transformed values. Confounders with a P value of less than 0.05 were retained. Other variables had no impact on the results, were not significant, and not retained. Model assumptions were checked by histograms and quantile-quantile plots of residuals. RESULTS Descriptive analysis Among 818 men who were 60 and over at baseline, 653 drank alcohol on a regular basis, i.e., at least one unit per week. Wine accounted for 92% of the alcohol consumed. In addition, 123 men drank beer, 295 drank aperitif and 20 men drank liqueurs on a regular basis (≥1 unit/week). Men reporting the highest intake drank on average 312 g/week (median IQR, 234, 406). When men were stratified according to average alcohol intake at baseline, age, body height, AAC score and estimated GFR significantly differed between the groups without consistent patterns (Table 1). Men who drank <16 g/week (<1 unit/week or total abstention) had higher BMI, but lower grip strength and lower physical function score in comparison with other groups. They self-reported less leisure physical activity than other groups. These men reported self-perceived excellent or good health status and treatment with fibrates less frequently, but the treatment with proton pump inhibitors (PPIs) more often than other groups. Finally, men who self-reported the lowest alcohol intake had lower average 25(OH)D concentration, but higher concentrations of PTH and OPG in comparison with other groups. Other variables did not vary significantly between the groups. Alcohol intake and bone microarchitecture at baseline – cross-sectional study No differences in aBMD were observed across categories of alcohol intake (Supplementary Table 1). At the distal radius, a weakly significant trend to higher trabecular area (Tb.Ar) was found in men drinking >224 g/week (>2 units/day) (Table 2). Men who drank >224 g/week had lower Ct.Thd and lower Ct.BMD at the distal tibia in comparison with men who drank <16 g/week. A slight, but significant trend to lower cortical area (Ct.Ar) and to higher Tb.Ar at the distal tibia was also found in men who drank more. Other bone measures did not differ significantly between the groups. Alcohol intake and bone microarchitecture decline – prospective study Changes in aBMD and all bone microarchitecture measures were numerically the lowest in men drinking 16 to 112 g alcohol/week compared with other groups. Rates of changes in aBMD did not differ between the categories of alcohol intake (Supplementary Table 2). Changes in all bone measures were numerically lower in men drinking 16 to 112 g alcohol/week versus other groups. At the distal radius, Tb.BMD, s.e.Tb.BMD and Tb.N decreased more rapidly, whereas Tb.Spd and Tb.1/N.SD increased faster in men who drank <16 g/week vs. the reference group (P<0.005 to P<0.001) (Table 3, Fig. 1A, B). In men drinking >224 g/week, the decrease in Tb.N and Tb. BMD and the increase in Tb.Spd were more rapid versus the reference group. At the distal tibia, total volumetric BMD Ct.Thd, Ct.Ar, reaction force and failure load decreased faster (P<0.05 to P<0.005) in men who drank <16 g/week compared with the reference group (Table 4, Fig. 1C, D). In men drinking >224 g alcohol/week, Ct.Thd, Ct.Ar, Ct.BMD, reaction force, and failure load decreased more rapidly compared with the reference group. Changes in other bone microarchitecture measures at both the skeletal sites did not differ significantly between the groups. Greater bone decline in men with the lowest alcohol intake – post hoc analysis To explain the faster bone decline in men with the lowest alcohol intake, we compared this group with the reference. Men drinking <16 g/week were older (P<0.005). After adjustment for age, they had higher BMI, lower 25(OH)D levels, grip strength, and lower physical function score (all P<0.05) as well as less self-reported leisure physical activity (P<0.005). They self-reported the treatment with PPI more often and with fibrates less frequently vs. the reference group (P<0.01 and P<0.005, respectively, adjusted for age). Other variables (smoking, co-morbidities, self-perceived health status, prior fracture, treatments, sex steroid hormones, hs-CRP) did not differ significantly between these two groups. Of note, the initial models were adjusted for BMI, grip strength, and physical function score. The further adjustment for 25(OH)D (instead of PTH), leisure physical activity, PPI and fibrates had no impact on the results. DISCUSSION In a cohort of older men followed prospectively for 8 years, men who drank small amounts of alcohol had the slowest bone microarchitecture decline. By contrast, men who did not drink alcohol regularly (<1 unit/week or total abstention) and men who drank >2 units/day had faster decline of bone microarchitecture. The accelerated deterioration was found in trabecular bone at the distal radius and in cortical bone at the distal tibia. By contrast, the rate of aBMD decrease was not associated with the alcohol consumption. Finally, at baseline, aBMD and bone microarchitecture did not differ across the categories of alcohol in-take either. Lack of association between current alcohol intake and bone status at baseline is in line with prior cross-sectional studies. In bone biopsies, lower aBMD and lower trabecular bone volume were found mainly in long-term heavy drinkers.[6,10,11,18,32,33] Areal BMD inversely correlated with duration of alcohol abuse and cumulative alcohol intake.[15,20,34] However, this pattern was found mainly in individuals who drank >200 g alcohol daily on average. By contrast, in our study, the median alcohol consumption in the high intake group was ~45 g/day, thus, much less than that found in individuals treated for alcohol abuse who had decreased aBMD. Moderate alcohol intake (like in our study, i.e., social drinking) was not associated with low aBMD or poor bone microarchitecture.[16,19,35] In cross-sectional studies, it was rather associated with higher aBMD.[9,12–14,17,36,37] However, they should be assessed with caution because current aBMD depends on drinking habits during the entire lifespan, whereas current alcohol intake does not necessarily reflect lifetime habits. Current abstainers may have abused alcohol in the past and finally given up drinking for medical reasons. However, current bone status may reflect alcohol-related damage accumulated over decades and not the current drinking habits. Therefore, prospective studies may provide a more reliable assessment of the impact of alcohol on ageing-related changes in aBMD. Data from such studies are limited and mostly negative.[38–41] However, some analyses found slower bone loss at some skeletal sites in individuals who drank moderate amounts of alcohol.[39–41] Four factors may contribute to the discordant results. Firstly, social drinking may be associated with higher aBMD, whereas alcohol abuse may be associated with lower aBMD.[14,37] If this association is non-linear, alcohol intake should not be used as a continuous variable for the assessment of its effect on bone. Secondly, the impact of alcohol on bone may vary according to the beverage. Wine components may have protective effect, whereas data on beer and liquors are inconsistent.[37,40–42] In our study, >90% of consumed alcohol was wine and few men drank other alcohols. Thus, we cannot assess differences between the alcohol beverages. Thirdly, the effect of alcohol may vary between the weight-bearing and non-weight-bearing sites. Finally, the impact of alcohol may differ between cortical and trabecular bone.[19,32,43] DXA does not make a distinction between the compartments and may miss mild loss in one compartment. Indeed, our data are consistent with these possibilities. Men with the alcohol intake <16 g/week had faster bone decline than men who drank small amounts (reference). An underlying mechanism may be that polyphenols present in wine mitigate bone loss in the reference group. Polyphenols include flavonoids (red wine) and non-flavonoid phenolics (more in white wine).[44,45] Flavonoids comprise anthocyanins (e.g., malvidin, cyanidin), flavonols (e.g., quercetin), flavanols (e.g., catechin, epicatechin), etc. Non-flavonic phenols include stilbenes (e.g., resveratrol, piceatannol), hydroxycinnamic acids (e.g., tartaric acid and its esters, caffeic acid), etc. Wine phenolic compounds stimulate osteoblast differentiation and proliferation. Moreover, they decrease the synthesis of pro-inflammatory cytokines and reactive oxygen species leading to the reduction of osteoclast differentiation and activity. If so, the difference between the lowest intake group and the reference group might be due to the better protection of bone by phenolics in the latter one. An alternative hypothesis is that low alcohol intake or abstention can be due to poor health.[21] However, there were no consistent differences in the prevalence of co-morbidities and treatments between this and the reference group. Men from the lowest alcohol intake group had lower grip strength, poorer physical function of the lower limbs and lower self-reported leisure physical activity. However, the associations between alcohol intake and bone measures persisted after adjustment for the measures of frailty severity (grip strength, physical function). Obviously, unmeasured residual confounding (e.g., more severe or unknown diseases) remains possible in this observational study. Low physical activity and low alcohol intake may be associated with poor social participation.[46] However, poor social network was associated with higher odds of osteoporosis.[47] Thus, faster bone microarchitecture decline in men with the lowest alcohol intake may be related to social isolation, frailty and poor ageing, of which low alcohol intake is only a proxy marker. Conversely, in men with the highest alcohol intake, faster bone microarchitecture decline may be due to the effect of alcohol itself. Bone histomorphometric studies showed consistently lower bone formation and mineralization in individuals abusing alcohol.[4,6,43] By contrast, data on bone resorption were inconsistent.[4,6,43] Consequently, the imbalance between low bone formation and unchanged bone resorption could result in lower bone volume.[4,33,43] Both the lowest and the highest alcohol intake resulted in faster bone microarchitecture decline of trabecular bone at the radius and of cortical bone at the tibia. The distal radius is a non-weight-bearing site; thus, the effect of the alcohol-related abnormalities (deficit of wine phenolics, high alcohol amounts) may be greater in trabecular bone which has higher metabolically available surface. At the weight-bearing distal tibia, the alcohol-related abnormalities may induce greater damage in the cortical bone which undergoes higher mechanical strain and may be sensitive to harmful factors. Moreover, this damage was associated with a compromised bone strength. This interpretation is plausible, but remains a speculation. Our study has limitations. This single center cohort consists of home-dwelling Caucasian men living in Greater Lyon. Our results cannot be extrapolated on women or other ethnicities. Of note, the association between alcohol intake and bone may depend on the preferred alcohol in various populations (wine, beer, strong alcohols).[37] Older volunteers for observational studies may be healthier than their peers. Drinking habits were assessed at baseline and was limited to self-report. Participants could underestimate the alcohol intake. Alcohol intake could vary during the follow-up, e.g., it could decrease with ageing and health problems. These changes were not likely to have an impact in man with the lowest alcohol intake, but could reduce the bone decline induced by the high alcohol intake. Partial-volume effect may bias bone measures in HRpQCT. Identification of the common segment may be imperfect due to different positions and angles during the follow-up. Longitudinal study is biased by cortical trabecularization because cortical remnants included in trabecular bone falsely decreases trabecular bone loss and overestimates cortical bone loss. Tb.Thd, Tb.1/N.SD and Ct.Thd are calculated. Our μFE analysis evaluates only compression, but no other deformations. However, the real-life fracture is determined by multidirectional loadings which vary according to the fracture site. Blood was collected in the non-fasting status in the early afternoon and only at baseline. Overall, in older men, both high and very low alcohol intake (including abstention) were associated with faster bone microarchitecture decline, but not with faster aBMD decrease. Alcohol intake was not associated with bone microarchitecture or aBMD at baseline. Our data improve understanding of the association between social alcohol drinking and bone status and of the discordant results. In a cross-sectional study, the link between alcohol intake and bone may be biased by prior drinking habits. The association between alcohol and bone status is not linear. Obviously, the “safe” amount of alcohol on bone should be interpreted in the context of the effect of alcohol on other organs. The impact of alcohol on one bone compartment may be missed by DXA and should be assessed by HR-pQCT which separates the compartments. Our data show that these two extreme groups may have faster bone microarchitecture decline and need a fracture risk assessment. In addition, further studies should assess the impact of alcohol abuse on the bone microarchitecture deterioration.